BRAIN STIMULATION: Basic, Translational, and Clinical Research in Neuromodulation
Volume 3, Issue 1 , Pages 15-21 , January 2010

Effects of intravenous antidepressant drugs on the excitability of human motor cortex: a study with paired magnetic stimulation on depressed patients

  • Alessandra Minelli

      Affiliations

    • Genetics Unit, IRCCS “Centro S. Giovanni di Dio” Fatebenefratelli, Brescia, Italy
    • Corresponding Author InformationCorrespondence: Dr. Alessandra Minelli, Genetics Unit, IRCCS “Centro S. Giovanni di Dio” Fatebenefratelli, Via Piastroni 4, 25123 Brescia, Italy.
    • ,
  • Marco Bortolomasi

      Affiliations

    • Casa di Cura “Villa S. Chiara,” Verona, Italy
    • ,
  • Catia Scassellati

      Affiliations

    • Genetics Unit, IRCCS “Centro S. Giovanni di Dio” Fatebenefratelli, Brescia, Italy
    • ,
  • Beatrice Salvoro

      Affiliations

    • Casa di Cura “Villa S. Chiara,” Verona, Italy
    • ,
  • Mirko Avesani

      Affiliations

    • Department of Neurological and Visual Sciences, Rehabilitative Neurology Section, University of Verona, Italy
    • ,
  • Paolo Manganotti

      Affiliations

    • Department of Neurological and Visual Sciences, Rehabilitative Neurology Section, University of Verona, Italy

Received 11 December 2007 ,Revised 24 February 2009 ,Accepted 21 April 2009.

References 

  1. Tardito D, Perez J, Tiraboschi E, et al. Signaling pathways regulating gene expression, neuroplasticity, and neurotrophic mechanisms in the action of antidepressants: a critical overview. Pharmacol Rev. 2006;58:115–134
  2. Rossini PM, Rossi S. Transcranial magnetic stimulation: diagnostic, therapeutic, and research potential. Neurology. 2007;68:484–488
  3. Caramia MD, Cicinelli P, Paradiso C, et al. Excitability changes of muscular responses to magnetic brain stimulation in patients with central motor disorders. Electroencephalogr Clin Neurophysiol. 1991;81:243–250
  4. Inghilleri M, Berardelli A, Marchetti P, et al. Effects of diazepam, baclofen and thiopental on the silent period evoked by transcranial magnetic stimulation in humans. Exp Brain Res. 1996;109:467–472
  5. Ziemann U, Lonnecker S, Steinhoff BJ, et al. Effects of antiepileptic drugs on motor cortex excitability in humans: a transcranial magnetic stimulation study. Ann Neurol. 1996;40:367–378
  6. Manganotti P, Bortolomasi M, Zanette G, et al. Intravenous clomipramine decreases excitability of human motor cortex: a study with paired magnetic stimulation. J Neurol Sci. 2001;184:27–32
  7. Ilic TV, Korchounov A, Ziemann U. Complex modulation of human motor cortex excitability by the specific serotonin re-uptake inhibitor sertraline. Neurosci Lett. 2002;319:116–120
  8. Eichhammer P, Langguth B, Wiegand R. Allelic variation in the serononin transporter promoter affects neuromodulatory effects of a selective serotonin transporter reuptake inhibitor (SSRI). Psychopharmacology. 2003;49:881–883
  9. Robol E, Fiaschi A, Manganotti P. Effects of citalopram on the excitability of the human motor cortex: a paired magnetic stimulation study. J Neurol Sci. 2004;221:41–46
  10. Gerdelat-Mas A, Loubinoux I, Tombari D, et al. Chronic administration of selective serotonin reuptake inhibitor (SSRI) paroxetine modulates human motor cortex excitability in healthy subjects. Neuroimage. 2005;27:314–322
  11. Münchau A, Langosch JM, Gerschlager W, et al. Mirtazapine increases cortical excitability in healthy controls and epilepsy patients with major depression. J Neurol Neurosurg Neuropsychiatry. 2005;76:527–533
  12. Reis J, John D, Heimeroth A, et al. Modulation of human motor cortex excitability by single doses of amantadine. Neuropsychopharmacology. 2006;31:2758–2766
  13. Langguth B, Eichhammer P, Spranz C, et al. Modulation of human motor cortex excitability by quetiapine. Psychopharmacology (Berl). 2008;196:623–629
  14. Solinas C, Lee YC, Reutens DC. Effect of levetirecetam on cortical excitability: a transcranial magnetic stimulation study. Eur J Neurol. 2008;15:501–505
  15. Mavroudakis N, Caroyer JM, Brunko E, et al. Effects of diphenylhydantoin on motor potentials evoked with magnetic stimulation. Electroencephalogr Clin Neurophysiol. 1994;93:428–433
  16. Manganotti P, Bongiovanni LG, Zanette G, et al. Cortical excitability in patients after loading doses of lamotrigine: a study with magnetic brain stimulation. Epilepsia. 1999;40:316–321
  17. Boroojerdi B, Battaglia F, Muellbacher W, et al. Mechanisms influencing stimulus-response properties of the human corticospinal system. Clin Neurophysiol. 2001;112:931–937
  18. Ziemann U, Lonnecker S, Steinhoff BJ, et al. The effects of lorazepam on the motor cortical excitability in man. Exp Brain Res. 1996;109:127–135
  19. Di Lazzaro V, Oliviero A, Meglio M, et al. Direct demonstration of the effect of lorazepam on the excitability of the human motor cortex. Clin Neurophysiol. 2000;111:794–799
  20. Di Lazzaro V, Oliviero A, Saturno E, et al. Effects of lorazepam on short latency afferent inhibition and short latency intracortical inhibition in humans. J Physiol. 2005;564:661–668
  21. Di Lazzaro V, Pilato F, Dileone M, et al. Dissociated effects of diazepam and lorazepam on short latency afferent inhibition. J Physiol. 2005;569:315–323
  22. Liepert J, Schwenkreis P, Tegenthoff M, et al. The glutamate antagonist riluzole suppresses intracortical facilitation. J Neural Transm. 1997;104:1207–1214
  23. Ziemann U, Tergau F, Bruns D, et al. Changes in human motor cortex excitability induced by dopaminergic and anti-dopaminergic drugs. Electroencephalogr Clin Neurophysiol. 1997;105:430–437
  24. Koran LM, Sallee FR, Pallanti S. Rapid benefit of intravenous pulse loading of clomipramine in obsessive-compulsive disorder. Am J Psychiatry. 1997;154:396–401
  25. Fallon BA, Liebowitz MR, Campeas R, et al. Intravenous clorimipramine for obsessive compulsive disorder refractory to oral clorimipramine. Arch Gen Psychiatry. 1998;55:918–924
  26. Mathew SJ, Coplan JD, Perko KA, et al. Neuroendocrine predictors of response to intravenous clomipramine therapy for refractory obsessive-compulsive disorder. Depress Anxiety. 2001;14:199–208
  27. Fountoulakis KN, Iacovides A, St Kaprinis G. Combined oral venlafaxine and intravenous clomipramine-A: successful temporary response in a patient with extremely refractory depression. Can J Psychiatry. 2004;49:73–74
  28. Hyttel J, Arnt J, Sanchez C. The pharmacology of citalopram. Rev Contemp Pharmacother. 1995;6:271–285
  29. Stahl SM. Using secondary binding properties to select a not so selective serotonin reuptake inhyibitor. J Clin Psychiatry. 1998;154:668–673
  30. Noble S, Benfield P. Citalopram: a review of its pharmacology, clinical efficacy and tolerability in the treatment of depression. CNS Drugs. 1997;8:410–432
  31. Keller MB. Citalopram therapy for depression: a review of 10 years of European experience and data from U.S. clinical trials. J Clin Psychiatry. 2000;61:896–908
  32. Kasper S, Muller-Spahn F. Intravenous antidepressant treatment: focus on citalopram. Eur Arch Psychiatry Clin Neurosc. 2002;252:105–109
  33. Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry. 1979;134:382–389
  34. Rossini PM, Barker AT, Berardelli A, et al. Non-invasive electrical and magnetic stimulation of the brain, spinal cord and roots: basic principles and procedures for routine clinical application. Report of an IFCN committee. Electroencephalogr Clin Neurophysiol. 1994;91:79–92
  35. Kujirai T, Caramia MD, Rothwell JC, et al. Cortico-cortical inhibition in human motor cortex. J Physiol (Lond). 1993;471:501–519
  36. Ziemann U, Lonnecker S, Paulus W. Inhibition of human motor cortex by ethanol: a transcranial magnetic stimulation study. Brain. 1995;118:1437–1446
  37. Siebner HR, Rothwell J. Transcranial magnetic stimulation: new insights into representational cortical plasticity. Exp Brain Res. 2003;148:1–16
  38. Chen R. Interactions between inhibitory and evcitatory circuits in the human motor cortex. Exp Brain Res. 2004;154:1–10
  39. Manganotti P, Zanette G, Bonato C, et al. Crossed and direct effects of digital nerves stimulation on motor evoked potential: a study with magnetic brain stimulation. Electroencephalogr Clin Neurophysiol. 1997;105:280–289
  40. Triggs WJ, Macdonell RA, Cros D, et al. Motor inhibition and excitation are independent effects of magnetic cortical stimulation. Ann Neurol. 1992;32:345–351
  41. Bezchlibnyk-Butler K, Aleksic I, Kennedy SH. Citalopram—a review of pharmacological and clinical effects. J Psychiatry Neurosci. 2000;25:241–254
  42. Werhahn KJ, Kunesch E, Noachtar S, et al. Differential effects on motorcortical inhibition induced by blockade of GABA uptake in humans. J Physiol. 1999;517:591–597
  43. Baldessarini RJ. Current status of antidepressants: clinical pharmacology and therapy. J Clin Psychiatry. 1989;50:117–126
  44. Baldessarini RJ. Treatment of depression by altering monoamine metabolism: precursors and metabolic inhibitors. Psychopharmacol Bull. 1984;20:224–239
  45. Kupfer DJ, Spiker DG, Coble PA, et al. Sleep and treatment prediction in endogenous depression. Am J Psychiatry. 1981;138:429–434

PII: S1935-861X(09)00052-7

doi: 10.1016/j.brs.2009.04.003

BRAIN STIMULATION: Basic, Translational, and Clinical Research in Neuromodulation
Volume 3, Issue 1 , Pages 15-21 , January 2010

Article Tools

* Image Usage & Resolution